HCWB — Hcw Biologics Balance Sheet
0.000.00%
Last trade - 00:00
- $63.54m
- $66.25m
- $2.84m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 7.36 | 8.46 | 36.7 | 32.1 | 3.6 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0 | 2.5 | 0.133 | 0.418 | 1.54 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 8.03 | 12.1 | 40.5 | 34.1 | 6.4 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2 | 1.62 | 1.12 | 10.8 | 20.5 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 10.1 | 15.4 | 53.5 | 46.8 | 28.5 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 1.07 | 1 | 2.32 | 2.96 | 8.75 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.07 | 1 | 2.32 | 9.38 | 15.1 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 9 | 14.4 | 51.2 | 37.4 | 13.5 |
Total Liabilities & Shareholders' Equity | 10.1 | 15.4 | 53.5 | 46.8 | 28.5 |
Total Common Shares Outstanding |